Australia markets closed

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
52.50-0.68 (-1.28%)
At close: 04:00PM EST
52.20 -0.30 (-0.57%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 45.91B
Enterprise value 79.99B
Trailing P/E 7.73
Forward P/E 10.64
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.34
Price/book (mrq)1.75
Enterprise value/revenue 0.59
Enterprise value/EBITDA 8.63

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 39.79%
S&P500 52-week change 314.07%
52-week high 357.05
52-week low 343.62
50-day moving average 350.00
200-day moving average 350.24

Share statistics

Avg vol (3-month) 36.12M
Avg vol (10-day) 36.24M
Shares outstanding 5863.27M
Implied shares outstanding 6N/A
Float 8714.03M
% held by insiders 117.33%
% held by institutions 158.19%
Shares short (30 Dec 2021) 415.35M
Short ratio (30 Dec 2021) 42.56
Short % of float (30 Dec 2021) 42.15%
Short % of shares outstanding (30 Dec 2021) 41.78%
Shares short (prior month 29 Nov 2021) 418.95M

Dividends & splits

Forward annual dividend rate 41.91
Forward annual dividend yield 43.64%
Trailing annual dividend rate 31.89
Trailing annual dividend yield 33.55%
5-year average dividend yield 43.10
Payout ratio 427.47%
Dividend date 309 Dec 2021
Ex-dividend date 411 Nov 2021
Last split factor 22:1
Last split date 315 Feb 1999

Financial highlights

Fiscal year

Fiscal year ends 30 Aug 2021
Most-recent quarter (mrq)29 Nov 2021

Profitability

Profit margin 4.76%
Operating margin (ttm)2.91%

Management effectiveness

Return on assets (ttm)2.65%
Return on equity (ttm)21.71%

Income statement

Revenue (ttm)134.97B
Revenue per share (ttm)156.05
Quarterly revenue growth (yoy)7.80%
Gross profit (ttm)28.07B
EBITDA 5.65B
Net income avi to common (ttm)5.97B
Diluted EPS (ttm)7.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.14B
Total cash per share (mrq)4.79
Total debt (mrq)39.23B
Total debt/equity (mrq)117.57
Current ratio (mrq)0.83
Book value per share (mrq)30.40

Cash flow statement

Operating cash flow (ttm)5.46B
Levered free cash flow (ttm)3.56B